| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells
|
Michelozzi, Ilaria M.
|
|
|
7 |
9 |
p. 1725-1738
|
artikel
|
| 2 |
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy
|
LoCastro, Marissa
|
|
|
7 |
9 |
p. 1871-1884
|
artikel
|
| 3 |
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
|
Bloedjes, Timon A.
|
|
|
7 |
9 |
p. 1697-1712
|
artikel
|
| 4 |
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
|
Wan, Jun
|
|
|
7 |
9 |
p. 1915-1925
|
artikel
|
| 5 |
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease
|
Martin de Frémont, Gregoire
|
|
|
7 |
9 |
p. 1682-1691
|
artikel
|
| 6 |
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function
|
Trory, Justin S.
|
|
|
7 |
9 |
p. 1692-1696
|
artikel
|
| 7 |
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
|
Carreño-Tarragona, Gonzalo
|
|
|
7 |
9 |
p. 1672-1681
|
artikel
|
| 8 |
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
|
Lachowiez, Curtis A.
|
|
|
7 |
9 |
p. 1899-1909
|
artikel
|
| 9 |
Cord blood power and the definition of success after BMT
|
Boelens, Jaap Jan
|
|
|
7 |
9 |
p. 1811-1812
|
artikel
|
| 10 |
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
|
Martinez, Caridad
|
|
|
7 |
9 |
p. 1823-1830
|
artikel
|
| 11 |
Curing CLL: one clone at a time
|
Aslan, Burcu
|
|
|
7 |
9 |
p. 1926-1928
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
7 |
9 |
p. i
|
artikel
|
| 13 |
Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model
|
Lay, Angelina J.
|
|
|
7 |
9 |
p. 1650-1665
|
artikel
|
| 14 |
Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
|
Panetti, Silvia
|
|
|
7 |
9 |
p. 1754-1761
|
artikel
|
| 15 |
Front Matter
|
|
|
|
7 |
9 |
p. ii
|
artikel
|
| 16 |
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
|
Chovanec, Jack
|
|
|
7 |
9 |
p. 1796-1810
|
artikel
|
| 17 |
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
|
Nguyen, Nam H. K.
|
|
|
7 |
9 |
p. 1769-1783
|
artikel
|
| 18 |
Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
|
Kelley, Rachel A.
|
|
|
7 |
9 |
p. 1813-1822
|
artikel
|
| 19 |
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy
|
Gonzalez, Michael A.
|
|
|
7 |
9 |
p. 1849-1853
|
artikel
|
| 20 |
Kindlin-3 deficiency leads to impaired erythropoiesis and erythrocyte cytoskeleton
|
Szpak, Dorota
|
|
|
7 |
9 |
p. 1739-1753
|
artikel
|
| 21 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
|
Clerici, Daniela
|
|
|
7 |
9 |
p. 1621-1634
|
artikel
|
| 22 |
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
|
Kennedy, Vanessa E.
|
|
|
7 |
9 |
p. 1713-1724
|
artikel
|
| 23 |
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
|
Osman, Afaf E. G.
|
|
|
7 |
9 |
p. 1910-1914
|
artikel
|
| 24 |
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
|
Naeem, Aishath
|
|
|
7 |
9 |
p. 1929-1943
|
artikel
|
| 25 |
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
|
Le, Quy
|
|
|
7 |
9 |
p. 1666-1670
|
artikel
|
| 26 |
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication
|
Paul, Helmut
|
|
|
7 |
9 |
p. 1831-1848
|
artikel
|
| 27 |
Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-3225.
|
|
|
|
7 |
9 |
p. 1671
|
artikel
|
| 28 |
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
|
Olsen, Kelly S.
|
|
|
7 |
9 |
p. 1635-1649
|
artikel
|
| 29 |
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
|
Schoettler, Michelle
|
|
|
7 |
9 |
p. 1784-1795
|
artikel
|
| 30 |
Soluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
|
Afangbedji, Nowah
|
|
|
7 |
9 |
p. 1854-1857
|
artikel
|
| 31 |
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
|
de Botton, Stéphane
|
|
|
7 |
9 |
p. 1858-1870
|
artikel
|
| 32 |
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones
|
Shaw, Lauren C.
|
|
|
7 |
9 |
p. 1885-1898
|
artikel
|
| 33 |
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
|
Davila, Jennifer
|
|
|
7 |
9 |
p. 1762-1768
|
artikel
|
Tijdschrift beschrijving